In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
  • Year

    Select Year(s)

  • Session Type

    Select Session Type(s)

  • Resource type

    Select Resource type(s)

  • Topic

    Select Topic(s)

Filters (0)
  • sub-topic
  • Year
  • Session Type
  • Resource type
  • Topic
  • sub-topic
  • Year
  • Session Type
  • Resource type
  • Topic

Sponsored content

Presentations below are part of sessions sponsored by Bayer

43 results for your search

2018

A holistic approach to cardiovascular protection with rivaroxaban.

Congress : ESC Congress 2018

  • Session : Rivaroxaban in cardiovascular protection - Getting to the heart of the matter
  • Speaker : A Kakkar (London,GB)
  • Sponsored by Bayer AG
2018

A paradigm shift becoming reality.

Congress : ESC Congress 2018

  • Session : Setting the COMPASS into new directions
  • Speaker : S Yusuf (Hamilton,CA)
  • Sponsored by Bayer AG
2018

Closing Remarks - Managing pulmonary embolism according to patient profile in the NOAC era.

Congress : ESC Congress 2018

  • Session : Managing pulmonary embolism according to patient profile in the NOAC era
  • Speaker : S V Konstantinides (Mainz,DE)
  • Sponsored by Bayer AG
2018

Closing remarks - Rivaroxaban in cardiovascular protection - Getting to the heart of the matter.

Congress : ESC Congress 2018

  • Session : Rivaroxaban in cardiovascular protection - Getting to the heart of the matter
  • Speaker : A J Camm (London,GB)
  • Sponsored by Bayer AG
2018

Closing remarks - Setting the COMPASS into new directions

Congress : ESC Congress 2018

  • Session : Setting the COMPASS into new directions
  • Speaker : K A A Fox (Edinburgh,GB)
  • Sponsored by Bayer AG
2018

Closing remarks - Translating real world evidence into your clinical practice for your multi-morbid patient

Congress : ESC Congress 2018

  • Session : Translating real world evidence into your clinical practice for your multi-morbid patient
  • Speaker : C T Ruff (Boston,US)
  • Sponsored by Bayer AG
2018

Complex patients profiles. What is the result with NOACs?

Congress : ESC Congress 2018

  • Session : Managing pulmonary embolism according to patient profile in the NOAC era
  • Speaker : D Jimenez (Madrid,ES)
  • Sponsored by Bayer AG
2018

Discussion - What are the clinical implications for your elderly patients?

Congress : ESC Congress 2018

  • Session : Translating real world evidence into your clinical practice for your multi-morbid patient
  • Speaker : C T Ruff (Boston,US), M Patel (Durham,US)
  • Sponsored by Bayer AG
2018

Discussion - What are the clinical implications of the data for your patients with renal impairment?

Congress : ESC Congress 2018

  • Session : Translating real world evidence into your clinical practice for your multi-morbid patient
  • Speaker : C T Ruff (Boston,US), M Patel (Durham,US)
  • Sponsored by Bayer AG
2018

From PE diagnose to extended treatment - What changed with NOACs?

Congress : ESC Congress 2018

  • Session : Managing pulmonary embolism according to patient profile in the NOAC era
  • Speaker : S V Konstantinides (Mainz,DE)
  • Sponsored by Bayer AG

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are